12 November 2020: Articles
Possible Azithromycin-Induced Life-Threatening Arrhythmia Requiring Extracorporeal Membrane Oxygenation Support: A Case Report
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Rare disease, Adverse events of drug therapy
Abdulrazaq S. Al-Jazairi A* , Haifa S. Alotaibi ADOI: 10.12659/AJCR.926951
Am J Case Rep 2020; 21:e926951
Table 2. Medications received by the patient during CS-ICU stay*.
| Medications | Duration |
|---|---|
| Amiodarone intravenous continuous infusion for a total of 10 g as loading dose | Day 1–Day 12 |
| Amiodarone 200 mg orally daily | Day 13–Day 17 |
| Heparin intravenous continuous infusion (hospital ECMO protocol) | Day 1–Day 12 |
| Nitroglycerin 200–150 mcg/min. intravenous continuous infusion | Day 1–Day 6 |
| Hydralazine 10–20 mg intravenous q 6h | Day 1–Day 13 |
| Nitroprusside 0.3–2 mcg/kg/min. intravenous continuous infusion | Day 2–Day 4 |
| Amlodipine 10 mg orally daily | Day 2–Day 13 |
| Metoprolol tartrate 12.5–50 mg orally twice daily | Day 3–Day 17 |
| Captopril 25 mg orally 3 times daily | Day 5–Day 14 |
| Vancomycin 1 g intravenous q 12h (adjusted according to patient’s renal function) | Day 2–Day 8 |
| Ceftazidime 1 g intravenous q12h (adjusted according to patient’s renal function) | Day 2–Day 8 |
| * CS-ICU=cardiac surgery intensive care unit, ** ECMO=extracorporeal membrane oxygenation support, *** hr=hour. | |